References
- Charlson M E, Horwitz R I. Applying results of randomized trials to clinical practice: impact of losses before randomization. Br Med J 1984; 289: 1281–1284
- Ashton M G, Holdsworth C D, Ryan F P, Moore M. Healing of gastric ulcer after one, two, and three months of ranitidine. Br Med J 1982; 284: 467–468
- Okada M, Yao T, Fuchigami T, Imamura K, Omae T. Factors influencing the healing rate of gastric ulcer in hospitalised subjects. Gut 1984; 25: 881–885
- Cochran K M, Cockel R, Crowe J, Dickinson R J, Gent A E, Kennedy N P, Royston C MS, Cedar E, Mann S G. Comparison of 40 mg famotidine nightly and 150 mg ranitidine b.d.: ulcer healing and symptom relief in benign gastric ulcer. Aliment Pharmacol Ther 1989; 3: 461–470
- Brazer S R, Tyor M P, Pancotto F S, Brice R S, Garbutt J T, Jr., Wildermann N M, Harrell F E, Pryor D B, Liss C L, Root J K, Humphries T J. Randomized, double-blind comparison of famotidine with ranitidine in treatment of acute, benign gastric ulcer disease. Dig Dis Sci 1989; 34: 1047–1052
- Blum A L, Bethge H, Bode J C, Domsche W, Feurle G, Hackenberg K, Hammer B, Hüttemann W, Jung M, Kachel G, Kaess H, Manegold B C, Peter P, Pleaders T, Rohner H G, Rasenack U, Sanwald R, Stalder G A, Vallotton J-J. Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study. Gut 1990; 31: 825–830
- Lahtinen J, Aukce S, Miettinen P, Poikolainen E, Pääkkönen M, Sandström R. Sucralfate and cimetidine for gastric ulcer. Scand J Gastroenterol 1983; 18(Suppl 83)49–51
- Naccaratto R, Cremer M, Dammann H G, Keohane P P, Mulder H, Sarles H, Simon B, Members of the European Nizatidine Gastric Ulcer Study Group. Nizatidine versus ranitidine in gastric ulcer disease. Scand J Gastroenterol 1987; 22(Suppl 136)71–78